•
•
•
•
•
•
•
•
Country
IN
Industry
Health Care
Market Cap
Mid Cap
Num. Employees
20122
IPO Date
Jan 1, 1986
Country
IN
Industry
Health Care
Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. The company is headquartered in Hyderabad, Telangana. The Company’s segments include Global Generics, which is engaged in manufacturing and marketing prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name (branded formulations) or as generic finished dosages with therapeutic equivalence to branded formulations (generics); Pharmaceutical Services and Active Ingredients (PSAI), which is engaged in manufacturing and marketing active pharmaceutical ingredients and intermediates for finished pharmaceutical products; Proprietary Products, which focuses on research and development of differentiated formulations and Others, which consists of the Company’s wholly-owned subsidiary, Aurigene Discovery Technologies Limited, which is a discovery stage biotechnology company developing novel and therapies in the fields of oncology and inflammation.
News Sentiment
Sentiment
Composite sentiment (positive vs. negative language) expressed across news sources mentioning this stock
Today
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Low Data
The average one-year price target for Dr. Reddy's Laboratories Limited - Depositary Receipt () (NYSE:RDY) has been revised to $16.18 / share.
Recent Mentions
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
Sources
Mentions
Mentions of this stock across all news source scraped in the past 30 days
Recent Mentions
Recent articles, blogs, and social posts pertaining to this stock
No data available
Related Stocks
Related Stocks
Stocks being mentioned with RDY